Cryolife Inc  

(Public, NYSE:CRY)   Watch this stock  
Find more results for CRY
+0.65 (3.13%)
Mar 16 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 20.80 - 21.45
52 week 14.02 - 24.00
Open 20.85
Vol / Avg. 365,420.00/120,721.00
Mkt cap 775.21M
P/E 212.57
Div/yield     -
EPS 0.10
Shares 36.49M
Beta 0.75
Inst. own 73%
May 17, 2018
CryoLife Inc Annual Shareholders Meeting (Estimated) - 9:00AM EDT - Add to calendar
Apr 24, 2018
Q1 2018 CryoLife Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 27, 2018
CryoLife Inc at Needham Healthcare Conference - 3:30PM EDT - Add to calendar
Mar 8, 2018
Q4 2017 CryoLife Inc Earnings Call - Webcast
Mar 7, 2018
Q4 2017 CryoLife Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin -6.17% 1.82%
Operating margin -0.37% 4.20%
EBITD margin - 9.34%
Return on average assets -2.86% 0.76%
Return on average equity -5.13% 1.39%
Employees 1,000 -
CDP Score - -


1655 Roberts Blvd NW
KENNESAW, GA 30144-3632
United States - Map
+1-770-4193355 (Phone)
+1-770-4260031 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


CryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix. PhotoFix is a pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde. The Preservation Services segment includes external services, such as preservation of cardiac and vascular tissues. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch, both of which are processed using CryoLife's SynerGraft technology.

Officers and directors

James Patrick Mackin Chairman of the Board, President, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
D. Ashley Lee CPA Chief Financial Officer, Chief Operating Officer, Executive Vice President
Age: 52
Bio & Compensation  - Reuters
James McDermid Chief Human Resource Officer, Senior Vice President
Age: 57
Bio & Compensation  - Reuters
Jean F. Holloway Esq. Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Age: 59
Bio & Compensation  - Reuters
John Davis Senior Vice President - Global Sales and Marketing
Age: 52
Bio & Compensation  - Reuters
Amy D. Horton CPA Chief Accounting Officer, Vice President
Age: 45
Bio & Compensation  - Reuters
Scott B. Capps Vice President - Clinical Research
Age: 50
Bio & Compensation  - Reuters
David C. Gale Ph.D. Vice President - Research & Development
Age: 49
Bio & Compensation  - Reuters
Thomas F. Ackerman Independent Director
Age: 62
Bio & Compensation  - Reuters
Daniel J. Bevevino Independent Director
Age: 57
Bio & Compensation  - Reuters